Merck MRK
NYSE MRK
$147.53 -0.93 (-0.63%)
As of: Sep 9, 2026 · 3:59 PM EDT

Merck (MRK) Current Taxes (2009 - 2026)

Merck's (MRK) quarterly Current Taxes came in at $4.2 billion in Q2 2026, up 1.64% year-over-year from $4.2 billion in Q2 2025, and up 7.05% quarter-over-quarter from $3.9 billion in Q1 2026.

Analysis

Merck (MRK) Current Taxes (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Current Taxes for 18 consecutive years, with $4.2 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Current Taxes rose 1.64% year-over-year to $4.2 billion in Q2 2026; TTM through Jun 2026 was $4.2 billion, a 1.64% increase from a year earlier, with the FY2025 full-year figure at $4.7 billion, up 20.75% from the prior year.
  • Current Taxes was $4.2 billion for Q2 2026 at Merck, up from $3.9 billion in the prior quarter.
  • Over five years, Current Taxes peaked at $5.2 billion in Q1 2025 and troughed at $1.4 billion in Q2 2022.
  • A 5-year average of $3.1 billion and a median of $2.7 billion in 2023 frame the typical range for Current Taxes.
  • Across the five-year window, Current Taxes soared 118.58% in 2024 and decreased 23.84% in 2026, its largest moves.
  • Over 5 years, Current Taxes stood at $2.0 billion in 2022, then soared by 33.38% to $2.6 billion in 2023, then jumped by 47.75% to $3.9 billion in 2024, then rose by 20.75% to $4.7 billion in 2025, then decreased by 10.62% to $4.2 billion in 2026.
  • The last three Current Taxes figures came in at $4.2 billion (Q2 2026), $3.9 billion (Q1 2026), and $4.7 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 1.05 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn -
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 4.22 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 2.31 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 653.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 1.03 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.22 Bn
Mar 31, 2026 3.95 Bn
Dec 31, 2025 4.73 Bn
Sep 30, 2025 4.85 Bn
Jun 30, 2025 4.16 Bn
Mar 31, 2025 5.18 Bn
Dec 31, 2024 3.91 Bn
Sep 30, 2024 4.33 Bn
Jun 30, 2024 2.78 Bn
Mar 31, 2024 2.40 Bn
Dec 31, 2023 2.65 Bn
Sep 30, 2023 1.98 Bn
Jun 30, 2023 1.49 Bn
Mar 31, 2023 1.87 Bn
Dec 31, 2022 1.99 Bn
Sep 30, 2022 1.70 Bn
Jun 30, 2022 1.44 Bn
Mar 31, 2022 1.57 Bn
Dec 31, 2021 1.22 Bn
Sep 30, 2021 954.00 Mn